Diabetes is associated with serious heart diseases such as atherosclerosis and heart failure, which are often caused by chronic inflammation. LXA4 reduces heart damage by helping eliminate inflammation. In animal models, LXA4 has been shown to reduce inflammation and scar tissue by half, improve heart muscle function, and prevent further damage.

Researchers found that LXA4 stimulates white blood cell repair, reduces scar formation, and improves overall heart function. It is noteworthy that these improvements occurred independently of blood sugar control.

LXA4-based therapy may be a new way to treat heart disease caused by diabetes. The team is currently working on developing a drug based on LXA4 and investigating its potential in the treatment of other inflammatory diseases.

News materials cannot be equated with a doctor’s prescription. Consult an expert before making a decision.

Source: Ferra

Previous articleSamsung’s new brand promotes Apple and its customers
Next articleCanada’s largest publications ChatGPT – OpenAIS sued science and technology writers December 1, 2024, 12:45
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.

LEAVE A REPLY

Please enter your comment!
Please enter your name here